Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ISLAA Foundation is a non-profit medical organization dedicated to advancing the science and clinical management of the left atrial appendage (LAA). Based in Overland Park, Kansas, the foundation co-sponsors the annual International Symposium on Left Atrial Appendage (ISLAA), a premier global educational event for cardiovascular specialists. Its mission focuses on improving patient outcomes through the dissemination of research on stroke prevention, atrial fibrillation, and innovative cardiac device technologies. The foundation collaborates with leading academic institutions, including the Mayo Clinic and Mount Sinai, to provide continuing medical education and clinical updates. By bridging the gap between emerging research and clinical practice, the ISLAA Foundation plays a key role in the evolution of cardiovascular care and electrophysiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISLAA Foundation.